As of April 16, 2025, Solid Biosciences (SLDB) has a market cap of $0.20 billion USD. According to our data, Solid Biosciences is ranked No.6979 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.20 B |
24.61%
|
Dec 31, 2024 | $0.16 B |
-34.85%
|
Dec 29, 2023 | $0.25 B |
14.13%
|
Dec 30, 2022 | $0.21 B |
-79.50%
|
Dec 31, 2021 | $1.05 B |
-76.91%
|
Dec 31, 2020 | $4.54 B |
70.34%
|
Dec 31, 2019 | $2.67 B |
-83.40%
|
Dec 31, 2018 | $16.06 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT
|
$5.33 B |
50.456 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.31 B |
-0.019 B
|
![]() USA
|
![]() Boundless Bio
BOLD
|
$29.32 M |
-0.780 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-8.966 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.28 B |
-0.038 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.22 B |
-0.124 B
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-4.979 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$41.02 M |
-2.741 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.64 B |
-0.060 B
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$55.03 M |
-2.830 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.17 B |
-4.969 M
|
![]() USA
|
Market Cap | = | SLDB Stock Price | * | SLDB Shares Outstanding |
= | $2.57 | * | 77.49 M | |
= | $0.20 B |